Bausch Health Companies (BHC) EBIAT: 2009-2025
Historic EBIAT for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $181.0 million.
- Bausch Health Companies' EBIAT rose 296.74% to $181.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.0 million, marking a year-over-year increase of 265.53%. This contributed to the annual value of -$72.0 million for FY2024, which is 88.22% up from last year.
- Latest data reveals that Bausch Health Companies reported EBIAT of $181.0 million as of Q3 2025, which was up 22.30% from $148.0 million recorded in Q2 2025.
- Over the past 5 years, Bausch Health Companies' EBIAT peaked at $403.0 million during Q3 2022, and registered a low of -$610.0 million during Q1 2021.
- In the last 3 years, Bausch Health Companies' EBIAT had a median value of -$47.0 million in 2023 and averaged -$39.0 million.
- Per our database at Business Quant, Bausch Health Companies' EBIAT crashed by 713.04% in 2022 and then skyrocketed by 1,380.00% in 2025.
- Bausch Health Companies' EBIAT (Quarterly) stood at $69.0 million in 2021, then slumped by 713.04% to -$423.0 million in 2022, then skyrocketed by 88.89% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then skyrocketed by 296.74% to $181.0 million in 2025.
- Its last three reported values are $181.0 million in Q3 2025, $148.0 million for Q2 2025, and -$86.0 million during Q1 2025.